Evidence map›Paper›PMID 28534515›Full record

ArticleOncogene2017

STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression.

K-J Kim, S-H Kwon, J-H Yun, H-S Jeong, H-R Kim, E H Lee, S-K Ye, C-H Cho

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Uncovering the Role ofJournal of Cancer · 2025
    Article
  8. Article
  9. The Brain Pre-Metastatic Niche: Biological and Technical Advancements.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Upcoming treatments for morphea.Immunity, inflammation and disease · 2021
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

K-J KimDepartment of Pharmacology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
S-H KwonDepartment of Pharmacology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
J-H YunDepartment of Pharmacology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
H-S JeongDepartment of Pharmacology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
H-R KimDepartment of Anatomy and Cell Biology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
E H LeeDepartment of Physiology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
S-K YeDepartment of Pharmacology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
C-H ChoDepartment of Pharmacology, College of Medicine, Seoul National University, Seoul, Republic of Korea.
Seoul National University · KRCatholic University of Korea · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis is a life-threatening feature of cancer and is primarily responsible for cancer patient mortality. Cross talk between tumor cells and endothelium is important for tumor progression and metastasis. However, very little is known about the mechanisms by which endothelial cells (ECs) that are close to tumor cells, respond to the tumor cells during tumor progression and metastasis. In this study, we exploited the use of EC-specific signal transducer activator of transcription 3 (STAT3) knockout mice to investigate the role of STAT3 in ECs in tumor progression and metastasis. We found that the loss of STAT3 in ECs did not affect primary Lewis lung carcinoma (LLC) tumor growth, but it reduced in vivo LLC metastasis in experimental and spontaneous metastasis models. Mechanistically, STAT3 activation upregulated cell adhesion molecule expression, including E-selectin and P-selectin, in murine endothelial MS-1 cells treated with tumor cell-conditioned media in vitro and in pre-metastatic lungs of tumor-bearing mice in vivo. We also found that both E-selectin and P-selectin were, at least in part, responsible for STAT3-induced adhesion and invasion of LLC cells through an EC monolayer. However, tumor cell-conditioned media from B16F10 melanoma cells did not activate STAT3 in MS-1 cells. As a result, EC STAT3 knockout did not affect B16F10 melanoma cell metastasis. In addition, various human cancer cells activated STAT3 in human ECs (HUVECs), resulting in increased cell adhesion molecule expression. Collectively, our findings demonstrate that STAT3 activation in ECs promotes tumor metastasis through the induction of cell adhesion molecules, demonstrating a role for ECs in response to tumor cells during tumor metastasis.

Indexed as

A549 CellsAnimalsCell Adhesion MoleculesCell CommunicationCell Line, TumorEndothelial CellsHCT116 CellsHumansMelanoma, ExperimentalMiceMice, Inbred C57BLMice, KnockoutNeoplasm MetastasisNeoplasmsSTAT3 Transcription FactorCell Adhesion MoleculesSTAT3 protein, humanStat3 protein, mouseSTAT3 Transcription Factor

Identifiers

PMID28534515
OpenAlexW2620162514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.